Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
Neoplasia. 2004 Sep-Oct;6(5):503-12. doi: 10.1593/neo.04157.
Neoplasia. 2004.
PMID: 15548358
Free PMC article.
APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers.
Gerstein AV, Almeida TA, Zhao G, Chess E, Shih IeM, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N.
Gerstein AV, et al.
Genes Chromosomes Cancer. 2002 May;34(1):9-16. doi: 10.1002/gcc.10037.
Genes Chromosomes Cancer. 2002.
PMID: 11921277
Item in Clipboard
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, Tchinda J, Tomlins SA, Hofer MD, Pienta KG, Kuefer R, Vessella R, Sun XW, Meyerson M, Lee C, Sellers WR, Chinnaiyan AM, Rubin MA.
Perner S, et al. Among authors: pienta kg.
Cancer Res. 2006 Sep 1;66(17):8337-41. doi: 10.1158/0008-5472.CAN-06-1482.
Cancer Res. 2006.
PMID: 16951139
Item in Clipboard
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.
Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN, Yang YC, Nyquist MD, Mostaghel E, Hsieh AC, Zhang X, Corey E, Brown LG, Nguyen HM, Pienta K, Ittmann M, Schweizer M, True LD, Wise D, Rennie PS, Vessella RL, Morrissey C, Nelson PS.
Bluemn EG, et al.
Cancer Cell. 2017 Oct 9;32(4):474-489.e6. doi: 10.1016/j.ccell.2017.09.003.
Cancer Cell. 2017.
PMID: 29017058
Free PMC article.
Item in Clipboard
New and emerging therapies for bone metastases in genitourinary cancers.
Saylor PJ, Armstrong AJ, Fizazi K, Freedland S, Saad F, Smith MR, Tombal B, Pienta K.
Saylor PJ, et al.
Eur Urol. 2013 Feb;63(2):309-20. doi: 10.1016/j.eururo.2012.10.007. Epub 2012 Nov 23.
Eur Urol. 2013.
PMID: 23201471
Free PMC article.
Review.
Item in Clipboard
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
Schweizer MT, True L, Gulati R, Zhao Y, Ellis W, Schade G, Montgomery B, Goyal S, Nega K, Hakansson AK, Liu Y, Davicioni E, Pienta K, Nelson PS, Lin D, Wright J.
Schweizer MT, et al.
J Urol. 2023 Feb;209(2):354-363. doi: 10.1097/JU.0000000000003038. Epub 2023 Feb 1.
J Urol. 2023.
PMID: 36621991
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite